$7.03 Billion is the total value of C WorldWide Group Holding A/S's 165 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 14.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HD | Sell | HOME DEPOT INC | $500,316,000 | -1.3% | 3,058,915 | -7.4% | 7.11% | -7.6% |
| PM | Sell | PHILIP MORRIS INTL INC | $313,707,000 | -6.1% | 2,825,935 | -0.6% | 4.46% | -12.1% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $39,084,000 | +1.8% | 199,563 | -3.7% | 0.56% | -4.6% |
| CL | Sell | COLGATE PALMOLIVE CO | $31,273,000 | -26.5% | 429,285 | -25.2% | 0.44% | -31.1% |
| MDLZ | Sell | MONDELEZ INTL INCcl a | $31,087,000 | -30.6% | 764,549 | -26.3% | 0.44% | -35.1% |
| CELG | Sell | CELGENE CORP | $26,105,000 | +9.2% | 179,019 | -2.7% | 0.37% | +2.2% |
| AMGN | Sell | AMGEN INC | $20,643,000 | +4.0% | 110,716 | -3.9% | 0.29% | -2.7% |
| PFE | Sell | PFIZER INC | $19,613,000 | +2.4% | 549,379 | -3.7% | 0.28% | -4.1% |
| AGN | Sell | ALLERGAN PLC | $19,488,000 | -18.9% | 95,086 | -3.7% | 0.28% | -24.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $17,356,000 | -17.1% | 210,627 | -5.8% | 0.25% | -22.3% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $16,383,000 | +10.1% | 257,031 | -3.7% | 0.23% | +3.1% |
| BIIB | Sell | BIOGEN INC | $15,551,000 | -12.3% | 49,665 | -24.0% | 0.22% | -17.8% |
| MRK | Sell | MERCK & CO INC | $12,858,000 | -3.6% | 200,817 | -3.5% | 0.18% | -9.4% |
| ABBV | Sell | ABBVIE INC | $12,731,000 | +2.6% | 143,271 | -16.2% | 0.18% | -3.7% |
| GOOGL | Sell | ALPHABET INCcap stk cl a | $12,677,000 | +4.5% | 13,019 | -0.3% | 0.18% | -2.2% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $11,496,000 | -16.7% | 81,944 | -27.8% | 0.16% | -22.4% |
| CI | Sell | CIGNA CORPORATION | $10,988,000 | -32.2% | 58,777 | -39.3% | 0.16% | -36.6% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $10,711,000 | +1.3% | 367,194 | -3.7% | 0.15% | -5.6% |
| LLY | Sell | LILLY ELI & CO | $10,703,000 | -0.3% | 125,120 | -4.1% | 0.15% | -6.7% |
| SHPG | Sell | SHIRE PLCsponsored adr | $10,600,000 | -10.7% | 69,219 | -3.7% | 0.15% | -16.1% |
| HCA | Sell | HCA HEALTHCARE INC | $10,396,000 | -12.4% | 130,618 | -4.1% | 0.15% | -17.8% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $10,099,000 | -11.3% | 92,393 | -4.0% | 0.14% | -16.8% |
| CNC | Sell | CENTENE CORP DEL | $9,063,000 | -44.3% | 93,653 | -54.0% | 0.13% | -47.8% |
| INCY | Sell | INCYTE CORP | $8,865,000 | -43.1% | 75,941 | -38.6% | 0.13% | -46.8% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,281,000 | -12.1% | 88,972 | -14.3% | 0.12% | -17.5% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $7,305,000 | -55.3% | 49,951 | -52.4% | 0.10% | -58.1% |
| EXAS | Sell | EXACT SCIENCES CORP | $7,215,000 | +25.4% | 153,130 | -5.9% | 0.10% | +18.4% |
| EXEL | Sell | EXELIXIS INC | $6,896,000 | -5.1% | 284,588 | -3.6% | 0.10% | -10.9% |
| MYL | Sell | MYLAN N V | $5,852,000 | -22.6% | 186,539 | -4.2% | 0.08% | -27.8% |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $5,724,000 | +11.9% | 230,900 | -7.2% | 0.08% | +3.8% |
| PODD | Sell | INSULET CORP | $5,568,000 | +1.3% | 101,083 | -5.6% | 0.08% | -4.8% |
| HZNP | Sell | HORIZON PHARMA PLC | $4,858,000 | +5.4% | 383,148 | -1.3% | 0.07% | -1.4% |
| NVCR | Sell | NOVOCURE LTD | $4,575,000 | -3.3% | 230,500 | -15.8% | 0.06% | -9.7% |
| CAH | Sell | CARDINAL HEALTH INC | $4,571,000 | -17.8% | 68,307 | -4.3% | 0.06% | -22.6% |
| XENT | Sell | INTERSECT ENT INC | $4,571,000 | +10.5% | 146,726 | -0.9% | 0.06% | +3.2% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $4,344,000 | -7.7% | 89,384 | -0.2% | 0.06% | -12.7% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $3,190,000 | -8.0% | 238,971 | -1.0% | 0.04% | -15.1% |
| DXCM | Sell | DEX INC | $2,781,000 | -37.8% | 56,835 | -7.0% | 0.04% | -41.2% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $2,846,000 | -7.9% | 71,143 | -0.7% | 0.04% | -14.9% |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $2,779,000 | -18.5% | 193,908 | -1.6% | 0.04% | -23.1% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $2,849,000 | -18.2% | 23,792 | -40.3% | 0.04% | -24.5% |
| NEO | Sell | NEOGENOMICS INC | $2,719,000 | +23.4% | 244,300 | -0.7% | 0.04% | +18.2% |
| TSRO | Sell | TESARO INC | $2,700,000 | -58.7% | 20,916 | -55.2% | 0.04% | -61.6% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,486,000 | -5.1% | 96,300 | -0.3% | 0.04% | -12.5% |
| ELGX | Sell | ENDOLOGIX INC | $2,200,000 | -9.7% | 493,325 | -1.5% | 0.03% | -16.2% |
| AQN | Sell | ALGONQUIN PWR UTILS CORP | $2,215,000 | -38.5% | 167,900 | -36.4% | 0.03% | -43.6% |
| MA | Sell | MASTERCARD INCORPORATEDcl a | $1,737,000 | -27.8% | 12,300 | -37.9% | 0.02% | -32.4% |
| STOR | Sell | STORE CAP CORP | $1,252,000 | -34.3% | 50,360 | -40.7% | 0.02% | -37.9% |
| FLKS | Sell | FLEX PHARMA INC | $889,000 | -17.0% | 260,584 | -6.3% | 0.01% | -18.8% |
| ARMK | Sell | ARAMARK | $625,000 | -63.3% | 15,400 | -63.0% | 0.01% | -65.4% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $550,000 | -82.0% | 80,000 | -39.2% | 0.01% | -82.6% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $268,000 | -5.0% | 5,285 | -4.5% | 0.00% | 0.0% |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -9,980 | -100.0% | -0.00% | – |
| TSS | Exit | TOTAL SYS SVCS INC | $0 | – | -10,300 | -100.0% | -0.01% | – |
| CCI | Exit | CROWN CASTLE INTL CORP NEW | $0 | – | -6,085 | -100.0% | -0.01% | – |
| CVX | Exit | CHEVRON CORP NEW | $0 | – | -7,700 | -100.0% | -0.01% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -592,946 | -100.0% | -0.04% | – |
| Exit | NEURODERM LTD | $0 | – | -92,800 | -100.0% | -0.04% | – | |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -73,180 | -100.0% | -0.04% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -58,443 | -100.0% | -0.09% | – |
| NKE | Exit | NIKE INCcl b | $0 | – | -190,523 | -100.0% | -0.17% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 37 | Q3 2023 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
| HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
| ICICI BK LTD | 37 | Q3 2023 | 2.1% |
| CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
| DEX INC | 37 | Q3 2023 | 0.5% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
| VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
| INSULET CORP | 37 | Q3 2023 | 0.3% |
| CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.